Nomura Holdings
HAE icon

Nomura Holdings’s Haemonetics HAE Stock Holding History

Nomura Holdings’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,799
Closed -$304K – 1873
2025
Q4 		$304K Buy
+3,799
New +$255K ﹤0.01% 1666
2025
Q1 		– Sell
-6,652
Closed -$519K – 2002
2024
Q4 		$519K Buy
+6,652
New +$534K ﹤0.01% 1788
2021
Q2 		– Sell
-9,310
Closed -$1.04M – 2145
2021
Q1 		$1.04M Sell
9,310
-7,398
-44% -$915K ﹤0.01% 1080
2020
Q4 		$1.98M Buy
+16,708
New +$1.8M ﹤0.01% 852
2015
Q3 		– Sell
-20,644
Closed -$842K – 1763
2015
Q2 		$842K Buy
+20,644
New +$870K ﹤0.01% 1091
2014
Q2 		– Sell
-9,688
Closed -$318K – 2859
2014
Q1 		$318K Sell
9,688
-7,648
-44% -$292K ﹤0.01% 2039
2013
Q4 		$732K Buy
+17,336
New +$713K ﹤0.01% 1115

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nomura Holdings's HAE Position: Q1 2026 in Review

Nomura Holdings sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 3,799 shares — an estimated $304K sold.

Nomura Holdings first reported a position in HAE in Q4 2013 and held it in 7 quarters. The position peaked at $1.98M in Q4 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Nomura Holdings reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 3,799 Haemonetics shares in Q1 2026, an estimated $304K.
  • Nomura Holdings first reported a position in Haemonetics in Q4 2013 and held it in 7 quarters.
  • Nomura Holdings's Haemonetics position peaked at $1.98M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.